FDA Inspection 1156373 — Versiti Indiana Inc
The FDA completed an inspection of Versiti Indiana Inc on Nov 2, 2021 in Dayton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 2, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Dayton, OH (United States)